A recent groundbreaking study published in Nature has opened a promising new chapter in the treatment of traumatic brain ...

Operator Welcome to BioNTech's fourth quarter and full year 2024 earnings call. I would like to hand the call over to Michael ...

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading ...

Mathematics undergraduate Caleb Chalmer’s submission was awarded top honors, with reviewers noting “a ghostly quality to it ...

Recurrent meningitis is a rare but serious condition, occurring in about 5% of cases of community-acquired meningitis.